|
Volume 271, Number 43,
Issue of October 25, 1996
pp. 26609-26615
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Protein PAB, an Albumin-binding Bacterial Surface Protein
Promoting Growth and Virulence*
(Received for publication, April 24, 1996, and in revised form, July 22, 1996)
Maarten
de Château
§,
Elisabet
Holst
¶ and
Lars
Björck
From the Departments of Cell and Molecular Biology
and ¶ Medical Microbiology, Lund University, P. O. Box 94, S-221 00 Lund, Sweden
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
The anaerobic bacterium Peptostreptococcus
magnus is a human commensal and pathogen. Previous work has shown
that strains of P. magnus isolated from patients with
gynecological disease (vaginosis) frequently express an immunoglobulin
(Ig) light chain-binding protein called protein L. Here we report that
strains isolated from localized suppurative infections bind human serum
albumin (HSA), whereas commensal isolates bind neither Ig nor HSA. The
HSA-binding protein PAB was extracted from the bacterial surface or
isolated from the culture supernatant of the P. magnus
strain ALB8. Protein PAB was shown to have two homologous HSA-binding
domains, GA and uGA. GA is absent in the sequence of a related protein
from another P. magnus strain and shows a high degree of
homology to the HSA-binding domains of streptococcal protein G. Therefore GA is believed to have recently been shuffled as a module
from genes of other bacterial species into the protein PAB gene. This
GA module was shown to exhibit a much higher affinity for HSA than uGA
and was also found to be present in all of the isolates tested from
localized suppurative infections, indicating a role in virulence.
Moreover, when peptostreptococci or streptococci expressing the GA
module were grown in the presence of HSA, the growth rate was
substantially increased. Thus, the HSA binding activity of the GA
module adds selective advantages to the bacteria, which increases their
virulence in the case of P. magnus strains.
INTRODUCTION
As a rule, anaerobic infections are caused by bacteria that are
part of the indigenous flora of mucosal surfaces and the skin.
Peptostreptococcus magnus is such a commensal, and it
belongs to the major group of anaerobic bacterial species causing
clinically significant infections (1). Still little is known about the
virulence factors of this bacterium. Increased oxygen tolerance, as
seen among clinical P. magnus isolates, could contribute to
the pathogenic potential (2). Other possible virulence factors, apart
from the herein discussed bacterial surface proteins, include
encapsulation (3) and collagenase production (4).
Numerous Gram-positive bacterial species and human pathogens express
structurally related surface proteins that interact mainly with soluble
host proteins (5). Protein A of Staphylococcus aureus and
protein G of human group C and G streptococci both interact with the Fc
region of IgG (6, 7, 8). Protein G also has affinity for human serum
albumin (HSA)1 (9), as do members of the M
protein family expressed by Streptococcus pyogenes (10, 11, 12).
Albumin binding has also been described for protein PAB
( eptostreptococcal inding) of
the anaerobic commensal and pathogen P. magnus (13). Protein
L is another surface protein of certain strains of P. magnus
that binds to immunoglobulin light chains (14). Protein L has been
shown to be a virulence determinant in bacterial vaginosis (15),
perhaps due to its histamine-releasing activity (16). M proteins
contribute to the virulence of S. pyogenes by their
antiphagocytic property (17), and also IgGFc-binding proteins of these
bacteria have been reported to be virulence factors (18). Experiments
with deletion mutants have likewise shown that protein A of S. aureus plays a role in virulence, possibly by inhibiting
opsonophagocytosis (19).
Host protein binding cell wall proteins of Gram-positive bacteria share
common primary structure motifs, including (from the distal
NH2 terminus) a signal sequence, a variable
NH2-terminal region, a varying number of repeated domains
that independently bind different plasma proteins, and a proline-rich
region supposedly intercalating the protein in the Gram-positive cell
wall, followed by a COOH-terminal cell wall sorting signal required to
anchor the protein to the cell wall (20). The gene structure of the
albumin-binding protein PAB has been shown to contain a centrally
located functional domain of 45 amino acid residues responsible for the
binding of HSA (Fig. 1). This domain has been subject to module
shuffling between bacterial species, and was subsequently named the GA
module, protein -related lbumin binding
module (13). Such shuffling of modules seems to be a persistent
activity among this group of genes, and when a consensus sequence of 15 nucleotides (called recer sequence) flanking the different
modules in the P. magnus family of surface proteins was
identified, a model for the shuffling of modules was proposed (21). The
albumin-binding protein G of group G streptococcal strain G148 carries
three GA modules in the NH2-terminal part of the protein
showing up to 60% identity to the shuffled module of protein PAB,
indicating that protein G might be the source of the GA module in
protein PAB. The secondary structure and global fold of the GA module
in protein PAB have been determined by NMR and were shown to adopt a
3-helix bundle (22), and the third GA module of protein G was recently
shown to exhibit the same structure (23). The predecessor of protein
PAB has also been identified. This protein, called urPAB, is expressed
by a strain that binds less albumin to its surface. Protein urPAB lacks
the shuffled GA module (21), but in the NH2-terminal
region, a domain (uGA) was identified showing 38% identity to the GA
module. Likewise, sequence comparison between proteins urPAB and PAB
revealed an analogous uGA domain in protein PAB, thus indicating the
presence of a second HSA-binding region in protein PAB (Fig.
1). HSA binding has been described for a number of
additional surface proteins of group C and G streptococci as well as
for a P. magnus protein that, in addition to several GA
modules, also contains Ig light chain-binding domains closely related
to those of protein L (24, 25, 26, 27). Apart from the HSA-binding proteins of
S. pyogenes that belong to the M protein family, the other
HSA-binding proteins all contain GA-related sequences. In the case of M
proteins, the binding of HSA is located to the so-called C repeats (10,
11), which show no homology to the GA module, suggesting that these
structures have evolved separately.
Fig. 1.
Schematic representation of proteins PAB,
urPAB, and G and recombinant fragments. Schematic gene
structures and structures of recombinant fragments are given in
box form. Common features for proteins PAB, urPAB, and G are
the signal peptide (ss), cell wall (W), and
membrane-spanning regions (M) as well as the different
HSA-binding GA domains (GA, uGA,
GA1-3). The C domains of proteins PAB and urPAB have no
known function. The C domains (C1-3) of protein G,
interspersed by linking domains (D1-2), bind IgGFc (39,
40). Numbers refer to amino acid positions. Accession
numbers of the sequences in the GenBankTM/EBI and PIR data
banks are: protein PAB, GB X77864 and PIR A53586; protein urPAB, GB
Z48975; and protein G, GB X04015.
[View Larger Version of this Image (28K GIF file)]
The aims of the present study were to further characterize the HSA
binding properties of protein PAB, to localize its HSA-binding regions,
and to compare the affinities of the shuffled GA module with that of
the uGA domains, i.e. the NH2-terminal
HSA-binding domains of proteins PAB and urPAB. It was believed that
this information could help to explain why the GA module has been
shuffled into protein PAB. The biological consequences of HSA binding
have also been investigated, and the results demonstrate that essential
properties such as bacterial growth and virulence are affected by the
interaction with albumin.
MATERIALS AND METHODS
Bacteria
P. magnus strains were clinical
isolates from the Department of Clinical Microbiology, Lund University
Hospital. The peptostreptococci were grown under strict anaerobic
conditions at 37 °C in Todd-Hewitt broth (Difco).
Proteins, Sera, and Labeling of Proteins
HSA and human IgG
were purified from human plasma (28). Other serum albumins and sera
were from Sigma. Protein L was prepared from
peptostreptococcal growth medium (15), and recombinant protein G was
from Escherichia coli lysates (9). Proteins were
radiolabeled with 125I using the Bolton-Hunter reagent
(Amersham Corp., Buckinghamshire, Great Britain), chloramine T, or
lactoperoxidase.
Binding Assay
Bacteria were suspended, heat killed
(80 °C, 5 min), and washed in phosphate-buffered saline (PBS)
containing 0.02% NaN3 and 0.5% Tween 20. Bacterial
suspensions of different concentrations in a volume of 100 µl were
mixed with 900 µl of Staphylococcus epidermidis strain
L603 (109 bacteria/ml). 200 µl of these mixed bacterial
suspensions were then incubated with 104 cpm of
125I-labeled HSA or IgG for 30 min. Cells were spun down,
and the radioactivity of the pellet was measured in a counter and
expressed as percentage of added radioactivity.
Solubilization of Peptostreptococcal
Proteins
Peptostreptococci were grown as described until the
stationary phase was reached and then harvested by centrifugation.
Subsequently, 10% solutions of the bacteria were boiled in HCl, pH
2.0, or NaOH, pH 11.0, vortexed in PBS, and treated with mutanolysin or
trypsin to extract surface proteins. Acid and alkali extractions were
performed by boiling the bacteria for 3 min in 0.1 M HCl or
NaOH, whereafter the sample was neutralized by the addition of 0.1 volume of 0.1 M Tris-HCl, pH 8.0. Extraction was done by
vortexing the bacterial suspension in PBS. Mutanolysin digestions were
performed in 0.01 M phosphate buffer, pH 6.8, and blocked
with NaHCO3 to pH 7.5 and by cooling on ice. Trypsin
digestions were done at pH 6.1 in 0.05 M phosphate buffer
containing 5 mM EDTA. Reactions were inhibited by adding
benzamidine to a final concentration of 5 mM. Enzyme
incubations were at 37 °C for 1-2 h.
Affinity Chromatography of Peptostreptococcal Protein PAB and an
E. coli-expressed Protein PAB Fragment
Culture medium from
peptostreptococci (strain ALB8) expressing protein PAB or periplasmic
E. coli lysates of clones expressing the 5 -end (nucleotides
1-857) of the protein PAB gene (pab) were used as starting
materials and subjected to affinity chromatography on HSA-Sepharose
CL-4B (Pharmacia Biotech Inc., Uppsala, Sweden). Columns of Sepharose,
coupled with 3-5 mg of HSA/ml of packed gel, were equilibrated in PBS.
The sample, in 0.01 M phosphate buffer, pH 7.5, was
applied, and the column was rinsed with PBS and then eluted with 0.1 M glycine buffer, pH 2.0. Eluates were immediately
neutralized by the addition of 0.1 volume of unbuffered 1 M
Tris.
Electrophoresis and Blotting of Proteins
Proteins were
separated by SDS-polyacrylamide gel electrophoresis (PAGE) (29) and
transferred to PVDF membranes (30). Agarose gel electrophoresis was
performed as described (31). Transfer of proteins from agarose gels was
done by applying PVDF membranes on top of the gels under pressure (1-2
kg).
Absorption Experiments with Peptostreptococci and Human
Plasma
P. magnus bacteria of strain 312 (109 cells) were incubated in 1 ml of human plasma for
2 h at 37 °C. The cells were spun down and washed five times in
PBS. The bacterial pellet was then resuspended in 50 µl of PBS and
boiled in an equal volume of SDS sample buffer. Cell debris was spun
down, and the supernatant was subjected to SDS-PAGE and Western blot
analysis (9).
Equilibrium Constants
Equilibrium constants were determined
by incubating constant amounts of Immunobeads (Bio-Rad), coupled with
HSA, together with 125I-labeled protein PAB or GA and
varying amounts of non-labeled proteins for 16 h at room
temperature. After washing, the amount of bound radioactivity was
measured. Using the formula of Scatchard, the calculations were done as
previously reported (32).
Mutanolysin Extraction of an Albumin Binding Surface Component
and Slot Binding Experiments
10% (v/v) solutions of strain ALB8
peptostreptococci were incubated for 2 h at 37 °C with
mutanolysin in 0.01 M phosphate buffer, pH 6.8. The
reaction was blocked with NaHCO3 to pH 7.5 followed by
cooling on ice. Cells were spun down, and material from the supernatant
was applied to PVDF membranes using a dot blot apparatus from
Schleicher & Schuell (Dassel, Germany). Incubation with radiolabeled
HSA was followed by autoradiography to visualize binding.
Preparation of Oligonucleotides, PCR Procedures, and Cloning and
Expression in E. coli
Five oligonucleotides were synthesized, all
of which include restriction site linkers (NarI and
SalI) for cloning in the expression vector pHD 389 (33):
RXN1, dGCT CAG GCG CGC CGG ACG AAC CCG GGG CAC CCA A; RXC3, dCAG CAG
GTC GAC TTA TTA AGC GTG TGC TTT TAA AAT TTC GTT; 1118, dCAG GTC GAC TTA
TTA TTC AGC TTC TAC TGG TGA TAA TAC; RKC1, dGGT GTT CTA GAT TAT TAT
(T/G)TT T(T/C)A GCT (T/G)TT TCT TCT TCT TTT; RXN0", dGCG AAT TCG GCG
CAT GAA AAT TAA TAA GAA ATT ATT. These oligonucleotides were used as
primers with genomic DNA from P. magnus strains ALB8 and
ALB1B as templates to generate inserts for cloning. PCR products were
purified by chloroform/phenol extraction and ethanol precipitation and
were subjected to restriction enzyme cleavage before a second
purification and ligation to the vector. Subsequently, the ligation
mixes were transformed into competent E. coli strain JM109
cells. Clones were selectively grown on ampicillin-containing plates
and were screened by PCR and for expression of HSA binding peptides.
HSA binding peptides were then purified by affinity chromatography on
HSA-Sepharose and on a gel chromatography column, Superose 12 for fast
protein liquid chromatography (Pharmacia). The purification of the GA
module has also been described elsewhere in more detail (22).
PCR Screening of P. magnus Isolates
Chromosomal DNA was
isolated from 15 HSA-binding strains of suppurative infections and from
10 non-binding, non-pathogenic isolates. These chromosomal preparations
were used as templates in PCRs using the following oligonucleotides as
primers: RX2N, dTTA AAG AAC GCT AAA GAA GAT GCA AT; 769, dGCT ACC AGC
TTT TGG TAA.
RESULTS
HSA-binding Proteins Are Preferentially Expressed by Strains of P. magnus Isolated from Patients with Localized Suppurative
Infections
Forty-eight P. magnus strains were isolated
from patients with localized suppurative infections (n = 30) or vaginosis (n = 8). Ten commensal isolates were
from healthy carriers. The ability of these strains to bind HSA and
human IgG was tested (Fig. 2). Among the 30 suppurative
infection isolates, 16 (53%) were HSA binding, whereas only one
isolate showed significant IgG binding. In the vaginosis group, on the
other hand, five of the eight isolates bound IgG and none bound HSA.
Finally, neither HSA nor IgG binding activity could be detected among
the commensal isolates. Thus, when the group of strains causing
suppurative infections was compared with the commensal strains, there
was a significant difference in the prevalence of HSA binding as tested
with the 2 test (p < 0.0001), implying
a role for protein PAB in virulence. The binding capacity of the
HSA-binding strains was shown to be saturable and varied among the
strains between 15 and 71% as tested by direct binding of radiolabeled
HSA to bacterial cells (Fig. 3). Among the HSA-binding
strains, strain ALB8 showing maximal binding (70%) and strain ALB1B
showing intermediate binding (27%) were chosen for further isolation
and characterization of the HSA-binding proteins PAB and urPAB,
respectively.
Fig. 2.
HSA and IgG binding activities among clinical
isolates of P. magnus. Clinical isolates of P. magnus from patients with localized suppurative infections
(n = 30, A) or vaginosis (n = 8, B) and commensal isolates (n = 10, C) were compared with regard both to their HSA ( ) and IgG
( ) binding capacities. Background level of binding is indicated by
the dashed line.
[View Larger Version of this Image (17K GIF file)]
Fig. 3.
Binding of radiolabeled HSA to different
strains of P. magnus. The binding of
125I-labeled HSA to six different strains of P. magnus was measured at bacterial concentrations varying from
105 to 109/ml. Strain 312 ( ) expresses
protein L, ALB8 ( ) protein PAB, and ALB1B protein urPAB ( ).
Albumin-binding strains ALB15 ( ) and ALB18 ( ), as well as the
non-binding strain 505 ( ), are also included.
[View Larger Version of this Image (25K GIF file)]
Isolation of the HSA-binding Protein PAB from P. magnus Strain
ALB8
After anaerobic growth of P. magnus strain ALB8
bacteria for 3 days in Todd-Hewitt broth, cells were collected by
centrifugation and washed in PBS. Different procedures to solubilize
HSA binding materials were tested. Boiling of the bacteria at low or
high pH in HCl and NaOH, respectively, released substantial amounts of
fragmented HSA-reactive material in the range of 14-45 kDa (Fig.
4). Similarly, degraded material could be obtained by
treatment of intact bacteria with the muranolytic enzyme mutanolysin,
whereas trypsin digestion resulted in extensive degradation. A higher
proportion of larger fragments could be obtained by simply vortexing
the bacteria in PBS. Still, a full-length molecule of 47 kDa was only
seen when the HSA-binding protein was isolated from the culture
supernatant by affinity chromatography on HSA-Sepharose. The protein
yield from the culture supernatant was approximately 1 mg/liter. The
NH2-terminal sequence of this 47-kDa material has been
shown to correspond to that of the NH2-terminal sequence of
protein PAB as deduced from the gene sequence (13). Mild treatment of
the material coming off the HSA-Sepharose column with trypsin resulted
in a single HSA binding fragment of 23 kDa.
Fig. 4.
Solubilization of protein PAB from P. magnus strain ALB8. Two SDS-PAGE gels loaded with the same
samples were run simultaneously. One was stained with Coomassie Blue,
and one was blotted onto PVDF and probed with 125I-labeled
HSA. Lane A, 20 µl of ALB8 growth medium; lane
B, supernatant following boiling of bacteria in 0.1 M
HCl; lane C, supernatant following boiling of bacteria in
0.1 M NaOH; lane D, supernatant following
vortexing of bacteria in PBS; lane E, supernatant following
mutanolysin digestion; lane F, supernatant following trypsin
digestion; lane G, protein PAB in the growth medium purified
on HSA-Sepharose; lane H, the material of lane G
following mild trypsin digestion.
[View Larger Version of this Image (47K GIF file)]
Protein PAB-expressing Bacteria and Purified Protein PAB Bind HSA
with High Specificity
Protein PAB-expressing bacteria were
incubated with human plasma. After incubation and washing, the bacteria
were boiled in SDS-PAGE sample buffer. Cells were spun down, and the
supernatant was run on a gel that was also blotted onto a PVDF membrane
and probed with radiolabeled protein PAB. As seen in Fig.
5, only a single band at 66 kDa representing HSA could
be adsorbed to the bacterial surface, and this band also reacted with
protein PAB in the Western blot experiment. The conclusion is that
neither the bacteria nor protein PAB will interact with any other
plasma protein than HSA. Subsequent tests of the binding of
125I-labeled protein PAB to a number of purified proteins
(i.e. IgG, IgA, fibrinogen, and fibronectin) in slot binding
experiments were also negative (not shown). In order to further analyze
the specificity of the interaction between protein PAB and HSA, human
plasma was run on agarose gels. After transfer to PVDF membranes, the
plasma proteins were probed with either protein L or protein PAB. As
seen in Fig. 6, protein L bound to the cathodal
immunoglobulin region of the plasma sample, whereas protein PAB bound
to the anodal albumin region. Proteins PAB and L were also applied to
the gel and were found to migrate in opposite directions to their
respective ligands. These results reflect that protein PAB is a basic
protein (net charge of +7, pI of 9.78), and protein L is an acidic
protein (net charge of 54).
Fig. 5.
Analysis of the interaction between protein
PAB and human plasma proteins. Two SDS-PAGE gels with the same
samples were run simultaneously. One was stained with Coomassie Blue,
and one was blotted onto PVDF and probed with 125I-labeled
protein PAB. Lane A, HSA; lane B, human
polyclonal IgG; lane C, 109 heat-killed P. magnus ALB8 bacteria were incubated with 1 ml of PBS for 2 h
in 37 °C. The cells were washed five times in PBS and boiled for 3 min in 1 ml of SDS-PAGE sample buffer containing 2% SDS and 5%
mercaptoethanol. The cells were spun down, and 50 µl of the
supernatant represents the sample in lane C. Lane
D, as in lane C but incubation with 1 ml of human
plasma instead of PBS; lane E, human plasma diluted 1:15 in
PBS.
[View Larger Version of this Image (38K GIF file)]
Fig. 6.
Analysis of the interactions between
peptostreptococcal proteins L and PAB and human plasmaproteins.
Samples of diluted plasma and purified IgG, HSA, and proteins PAB and L
were separated by agarose gel electrophoresis at pH 8.6. Two duplicates
of the first three samples were also transferred to PVDF membranes and
probed with radiolabeled proteins PAB and L, respectively. Lane
a, human plasma diluted 1:15; lane b, polyclonal IgG;
lane c, HSA; lane d, protein L (recombinant
B1-B4); lane e, protein PAB (recombinant RX1N/4C).
[View Larger Version of this Image (49K GIF file)]
Binding of Protein PAB to Mammalian Sera and Purified
Albumins
Sera from 10 different mammalian species were subjected
to SDS-PAGE. The separated proteins were blotted onto a PVDF membrane
and probed with radiolabeled protein PAB (Fig. 7).
Binding to the albumin band in serum from man, baboon, rhesus monkey,
rat, and cat was seen. Fig. 8 demonstrates that, also
among purified albumins from 12 mammalian species, protein PAB has
affinity for albumin from man, baboon, rhesus monkey, and rat (purified
cat serum albumin was not available).
Fig. 7.
Western blot analysis of the interaction
between protein PAB and serum proteins of different animal
species. Sera were separated under reducing conditions by
SDS-PAGE. The samples were analyzed by protein staining and by blotting
and subsequent probing with 125I-labeled protein PAB. The
position of the 66-kDa molecular mass marker is indicated.
[View Larger Version of this Image (35K GIF file)]
Fig. 8.
Binding of protein PAB to albumin from
different species. Dilution series (5, 1, 0.2, and 0.04 µg) of
albumin from different species were applied to a PVDF membrane in
slots. The membrane was probed with radiolabeled protein PAB.
[View Larger Version of this Image (23K GIF file)]
Characterization of Protein PAB Fragments Identifies Two Distinct
HSA-binding Sites
If P. magnus strain ALB8 bacteria
are grown in Todd-Hewitt broth until stationary phase, HSA binding
activity can be detected not only on the surface of the bacteria but
also in the culture supernatant. This material can be adsorbed to
HSA-Sepharose and then eluted at pH 2.0. The eluted proteins were
separated by SDS-PAGE and blotted onto two PVDF membranes. One was
probed with radiolabeled HSA, and the results demonstrated that the
majority of the bands still bound HSA (not shown). The other membrane
was stained with Coomassie Blue, and as seen in Fig. 9,
the HSA binding material coming off of the column is often size
heterogeneous. This could be due to partial hydrolysis at low pH or due
to proteolytic activity at the bacterial surface or in the culture
medium. The albumin binding bands at 47 (I), 24 (II), and 16 kDa (III) were cut out and subjected
to NH2-terminal sequencing. All three bands had the same
amino acid sequence, identical to the absolute NH2 terminus
of protein PAB. This shows that the fragments are derived from protein
PAB and that there must be an HSA-binding site in the most
NH2-terminal 130-140 amino acids, giving an approximate
molecular mass of 16 kDa. The same material was then subjected to mild
trypsin treatment, yielding a single major albumin-binding protein
species at 23 kDa (IV). The NH2-terminal
sequence of this fragment was MTIDQ which corresponds to the five amino
acid residues at positions 213-217 of protein PAB. This sequence is
found immediately in the NH2-terminal direction of the GA
module. From this, a second albumin-binding region in protein PAB is
implied as fragments III and IV do not overlap. In the region of
protein PAB covered by fragment I, at positions 57-101, a region
exhibiting 42% identity to the GA module has been found. This
GA-related domain was designated uGA since its counterpart was found in
the same position in the protein PAB predecessor, protein urPAB (Fig.
1) (21).
Fig. 9.
NH2-terminal sequencing of
protein PAB fragments recovered from culture supernatant and after
trypsin digestion. Samples were separated by SDS-PAGE and
transferred to a PVDF membrane. Samples were visualized by Coomassie
Blue staining, and selected bands (I-IV) were cut out and
subjected to NH2-terminal amino acid sequencing. Sequences
are given in panel A. Lanes A, protein PAB peptides
purified by affinity chromatography on HSA-Sepharose; lane
M, molecular mass markers; lanes B, same material as in
lanes A after mild digestion with trypsin.
[View Larger Version of this Image (34K GIF file)]
PCR Screening for the GA Module in Pathogenic P. magnus
Strains
To show that the recently introduced GA module
contributes to the pathogenicity of the HSA-binding strains causing
localized suppurative infections, 25 different P. magnus
strains were tested for the presence of the GA module. Chromosomal DNA
from the different strains was used as templates in polymerase chain
reactions. An oligonucleotide (RX2N) representing the 5 -end of the
recently introduced GA module of protein PAB and a second
oligonucleotide spanning the very well conserved cell wall anchor motif
(769) were used as primers in these reactions. DNA from the protein PAB
strain, which was used as a positive control, yielded a product of
approximately 450 base pairs. All 15 HSA-binding strains yielded
products of equal or near equal (±100 base pairs) sizes, whereas none
of the 10 non-binding strains yielded any PCR products with these
primers.
The Affinity for HSA Differs among GA Modules
To find an
explanation to why a second GA module has been introduced into protein
PAB, the affinity of this GA module was determined and compared with
the relative affinities of the uGA regions of proteins PAB and urPAB.
Recombinant fragments of proteins PAB and urPAB covering the three
resident GA modules were expressed in E. coli and purified
by affinity chromatography on HSA-Sepharose, followed by gel
filtration. Fragment AC corresponds to amino acid residues 27-195 of
protein PAB, containing the uGA and C domains. A second fragment (GA)
covers residues 213-265 of protein PAB containing the GA module,
whereas uGA-K is a fragment corresponding to the uGA region (positions
1-102) of protein urPAB (Fig. 1). These fragments together with
proteins urPAB and G were run on a Tricine-SDS-PAGE gel to show sizes
and purity (Fig. 10A). They were also
radiolabeled and allowed to bind to HSA in slot binding experiments
(Fig. 10B). In these experiments, the AC fragment bound
weakly, the GA module bound almost as strong as intact protein PAB
(compare with Fig. 8), and the uGA-K bound to an intermediate
degree.
Fig. 10.
A, SDS/PAGE showing recombinant
fragments and protein urPAB. Protein samples were separated by SDS-PAGE
using the Tricine buffer system (41). The gel was stained with
Coomassie Blue. Molecular mass markers are indicated. Protein fragments
were expressed in E. coli. Lane a,
peptostreptococcal protein urPAB; lane b, fragment GA-K of
protein urPAB; lane c, fragment AC of protein PAB;
lane d, fragment GA of protein PAB. B, binding of
recombinant fragments and protein urPAB to HSA. Dilution series (25, 5, 1, 0.2, and 0.04 µg) of HSA were applied to PVDF membranes in slots.
The membranes were probed with radiolabeled proteins. The probes were:
lane a, peptostreptococcal protein urPAB; lane b,
fragment GA-K of protein urPAB; lane c, fragment AC of
protein PAB; lane d, fragment GA of protein PAB.
C, Scatchard plots for the interactions between radiolabeled
fragment GA of protein PAB and immobilized HSA. A constant amount of
125I-fragment GA of protein PAB was mixed with a constant
amount of HSA-coupled polyacrylamide beads followed by the addition of
unlabeled protein. After 2 h at room temperature, the beads were
washed and centrifuged, and the radioactivity of the pellets was
determined. Bound and free protein concentrations were calculated and
plotted. The equilibrium constant for the interaction between fragment
GA of protein PAB and HSA was 6.7 × 109
M 1. D, competitive binding
experiments. The binding of radiolabeled fragment GA of protein PAB to
HSA, coupled to polyacrylamide beads, was inhibited with different
amounts of unlabeled protein urPAB ( ) or fragments GA ( ) and AC
( ) of protein PAB. Incubations were as described for the Scatchard
plots (C).
[View Larger Version of this Image (29K GIF file)]
A competitive binding assay was utilized to determine the equilibrium
constant of the interactions between HSA and fragment GA of protein
PAB, as well as the relative affinities of the three peptostreptococcal
GA modules. The affinity of fragment GA (the shuffled module) for HSA
was determined to be 6.7 × 109
M 1. Furthermore, HSA was coupled to
polyacrylamide beads and incubated with the radiolabeled GA fragment in
the presence of different amounts of non-labeled competing proteins
(Fig. 10D). The AC fragment could only interfere with the
binding of radiolabeled GA when added at a molar excess of >1000:1.
Protein urPAB was a much more efficient inhibitor but still not as
efficient as GA itself. Based on the amount of inhibitor needed to
elicit the same inhibitory effect on the binding of
125I-labeled GA to HSA, the relative affinities were 1, <0.05, and <0.001 for GA, uGA of protein urPAB, and uGA of protein
PAB, respectively.
Growth of HSA-binding Bacteria Is Stimulated by HSA
The
growth rates of albumin-binding strains of P. magnus and
group G streptococci were markedly increased upon the addition of HSA
to the growth medium (Fig. 11). In these experiments,
100 µl of overnight cultures were transferred to 12-ml tubes
containing plain Todd-Hewitt broth or broth supplemented with 0.5 mg/ml
HSA. The growing bacteria were sampled at certain time intervals by
plating out aliquots of the culture on blood agar plates for subsequent
colony counting or by measuring the optical density at 620 nm. These
two methods correlated well with each other, but since group G
streptococci grow much faster than P. magnus bacteria
in vitro, it was more practical to follow the growth of
group G streptococci by measuring the optical density. Under the
experimental conditions used, P. magnus reached stationary
phase after approximately 30 h as compared with 5 h for the
group G streptococci. As seen in Fig. 11, P. magnus strain
ALB8 grows faster at the beginning of the exponential phase in the
presence of HSA. The culture also reaches a higher cell density at the
end of the exponential phase. The group G streptococci also exhibit a
faster growth rate when HSA is present, and the doubling time decreases
from 30 to 20 min. When non-HSA-binding P. magnus strain
(505) was tested, HSA had no effect on the growth rate. Moreover, the
growth rates of the Ig-binding P. magnus strain 312 or group
G streptococcal strain G148 were not influenced by the addition of 0.5 mg/ml human polyclonal IgG (data not shown).
Fig. 11.
Growth curves of the HSA-binding P. magnus strain ALB8 (left) and group G
Streptococcus strain G148 (right). HSA
binding bacteria were grown in plain Todd-Hewitt broth ( ) or
Todd-Hewitt broth supplemented with 0.5 mg/ml of HSA ( ). Samples
were taken at regular time intervals, and culture density was measured
by colony counting (colony forming units) or by measuring
optical density at 620 nm.
[View Larger Version of this Image (16K GIF file)]
DISCUSSION
The Gram-positive obligate anaerobic peptostreptococci are part of
the human indigenous flora on the skin, in the oropharynx, and in the
gastrointestinal and genitourinary tracts. Among these commensals,
P. magnus is the species most often associated with
clinically significant infections. It is second in frequency only to
Bacteroides fragilis among obligate anaerobic bacteria
recovered from clinical isolates, accounting for about 10% of
anaerobic human infections. The isolates are often part of mixed
infections with other anaerobes and facultative anaerobes such as
S. aureus, but P. magnus can also be
found in pure isolates, a fact stressing its potential as a pathogen
(1). However, like most anaerobes, it is a low grade pathogen that will
probably not invade tissues unless preceded by trauma or other more
invasive pathogens (34). P. magnus will generally cause
localized suppurative infections or vaginosis. Localized suppurative
infections are understood as infection entities such as abscesses, soft
tissue, and wound infections. In the present study, 16 out of 30 isolates from localized suppurative infections were found to bind
significant amounts of HSA, whereas none of the vaginosis or commensal
isolates showed affinity for HSA (Fig. 2). Statistical analysis of
these figures, using the 2 test, demonstrated a
correlation between the albumin binding phenotype and suppurative
infections (p < 0.0001), implying a role for this
phenotype in virulence. Previously, P. magnus strains
expressing the Ig light chain-binding protein L have similarly been
associated with bacterial vaginosis, a condition characterized by
bacterial overgrowth in the vagina (15). In the current study, all
strains were tested for both HSA and Ig binding, and only one strain
expressing both activities could be identified. Such a strain
expressing a protein with sequence homologies both to the Ig light
chain-binding domains of protein L (35) and the GA module of protein
PAB was recently described (25). By PCR, the genes for proteins PAB,
urPAB, and L have been amplified with chromosomal DNA from the
corresponding strains as templates and by using the same sets of
oligonucleotides, representing both intra- and extragenic sequence
homologies (13, 21). These sequence homologies in the framework regions
of the genes suggest a common evolutionary origin. Applying the same
PCR reactions to the collection of non-binding strains even at low
stringency yielded no specific products. This indicates that there are
no silent or down-regulated copies of the genes in non-binding strains.
Moreover, the occurrence of these proteins appears to be a constant and
stable property as the level of expression has not changed over several
years of subculturing in our laboratory.
It was shown by examining fragments of peptostreptococcal protein PAB
(Fig. 9) and by studying recombinant fragments of protein PAB produced
in E. coli that there are two binding sites for HSA. This
fits well with the finding that the PAB gene sequence
contains two GA modules (21). When the sequences of the GA modules of
proteins PAB, urPAB, and GA3 of protein G are compared, it can be noted
that the pairwise alignments yield an identity of 29-42% of all pairs
with one exception; the GA modules (positions 214-265) of protein PAB
and GA3 of protein G are 60% identical at the protein level
(Fig. 12). The close relatedness of these two sequences
is also functionally emphasized since these two GA modules show equally
strong affinity for HSA, 6.7 × 109 and 2.6 × 109 M 1 (36), respectively.
Assuming that the different GA modules compete for the same binding
sites on HSA, the NH2-terminal uGA domains of proteins PAB
and urPAB were shown to have much weaker affinities for HSA. This fact
has implications for the interpretation of why the GA module was
probably shuffled into protein PAB more recently. The uGA domains are
located in analogous positions in proteins PAB and urPAB and can be
assumed to have evolved divergently in situ from a common
ancestor. uGA in protein PAB can therefore be said to be ``older''
than the more recently acquired GA. A reason for the organism to
acquire a new GA module could be that the old one had lost most of its
function, hence the difference in affinities.
Fig. 12.
Alignment of four GA modules of proteins
PAB, urPAB, and G. GA modules of proteins PAB
(ALB8-uGA and ALB8-GA) urPAB
(ALB1B-uGA), and G (G148-GA3) are designated by
strain numbers. The protein sequence alignment of the
different GA modules is shown, with identical residues in shaded
boxes. The consensus sequence is shown at the bottom.
The secondary structures of ALB8-GA (22) and G148-GA3 (23) are
comparable and schematically shown on top. The relative
affinities of the peptostreptococcal GA modules derived from Fig.
10D are shown to the far left. Three residues
(TSR) in ALB8-uGA and one (P) in ALB1B-uGA are
shown in bold because they are suggested to be responsible
for the lowered affinities for HSA in these modules as compared with
ALB8-GA. The equilibrium constant for the interaction between a protein
G fragment containing G148-GA3 and HSA has been determined previously
to be 2.6 × 109 M 1
(36).
[View Larger Version of this Image (23K GIF file)]
uGA of protein PAB has low affinity for HSA and differs in four amino
acid positions that are all conserved in the other three GA modules
with higher affinities (Ala-4, Glu-11, Lys-30, and Thr-31). A fifth
conserved position (Val-32) is changed to a proline residue in the uGA
domain of protein urPAB. The octapeptide region constituting residues
Ile-26 to Glu-33 is the only longer conserved region in 16 GA modules
from seven proteins compared. The GA modules of protein PAB (GA) and
protein G (GA3) have been investigated by NMR and were found to adopt
antiparallel 3-helix bundle structures (22, 23). In these structural
determinations, it was shown that residues 30-32 are part of a loop
between helix II and III and should therefore be accessible for
solvent. Taken together, these findings indicate that the binding site
for HSA is to be found in this octapeptide region of the GA module.
Bacteria are well adapted to exploit their nutritional environment, and
their growth rates can vary over more than a 10-fold range. The results
of Fig. 11 show that HSA-binding strains of P. magnus and
human group G streptococci grow with higher growth rates and to higher
maximum cell densities when HSA is present in the culture medium.
However, addition of IgG to the growth medium of comparable Ig-binding
strains (P. magnus strain 312 and group G streptococcal
strain G148) had no effect on the growth rates. Moreover, parallel
experiments with non-binding strains of P. magnus
demonstrated that the mere presence of HSA in the growth medium was not
enough to stimulate growth.
HSA is the sole or major transporter of such diverse ligands as long
and short fatty acids, tryptophan, thyroxine, calcium ions, etc.
HSA-binding bacterial surface proteins could therefore make these
ligands available for the bacteria. In this context it is noteworthy
that P. magnus grows better in the presence of Tween 80 (37), a detergent composed of 70% fatty acids. The plasma
concentration of free fatty acids (FFAs) is approximately 0.5 mM, and 99% of it is tightly bound to the FFA-binding
sites of HSA (three major sites per HSA molecule). A rapid turnover,
t1/2 in plasma is 2 min, sees to it that 50% of all
lipid transportation in the human body is carried out this way. The
average plasma concentration of HSA is 45 g/liter, and the protein is
also present extravascularly in most tissues and at mucosal surfaces in
inflammatory exudates. Albumin-binding bacteria will therefore have
ample access to HSA and its ligands. It is also likely that FFA
associated with HSA bound to the bacterial surface can be utilized as
nutrient. Thus, in the case of hepatocytes, the binding of HSA to a
surface protein is followed by the rapid diffusion of FFA across the
plasma membrane (38).
Previous studies have described the dynamic on-going evolution of HSA-
and Ig-binding surface proteins of P. magnus (13, 21). These
studies have also identified interdomain sequences, so-called
recer sequences, with intron-like function that have
promoted the evolution of this protein family (21). Here we find that
the binding of HSA stimulates bacterial growth. This growth stimulation
could constitute the selective pressure behind the evolution of protein
PAB as the shuffling of an additional GA module into protein PAB has
dramatically increased its affinity for HSA. Moreover, the presence of
GA in all of the isolates from patients with localized suppurative
infections supports the notion that this module adds to the
pathogenicity of these strains. Thus, as a consequence of the shuffling
of the GA module and the subsequent growth stimulation, protein
PAB-expressing strains have become more virulent.
FOOTNOTES
*
This work was supported by the Swedish Medical Research
Council (project 7480), the Medical Faculty at Lund University, the
Foundations of Österlund and Kock, the Swedish Council for
Engineering Sciences (project 123), and High Tech Receptor AB. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
``advertisement'' in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 46-46-222-4488;
Fax: 46-46-157756.
1
The abbreviations used are: HSA, human serum
albumin; PCR, polymerase chain reaction; PBS, phosphate-buffered
saline; PVDF, polyvinylidene difluoride; PAGE, polyacrylamide gel
electrophoresis; FFA, free fatty acids; Tricine,
N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine.
REFERENCES
-
Bourgault, A.-M.,
Rosenblatt, J. E.,
Fitzgerald, R. H.
(1980)
Ann. Intern. Med.
93,
244-248
-
Ezaki, T.,
Oyaizu, H.,
Yabuuchi, E.
(1992)
The Prokaryotes
(Balows, E.,
Trüper, H. G.,
Dworkin, M.,
Harder, W.,
Schleifer, K.-H.,
eds)
, 2nd Ed.
, Vol 2, p. 1879, Springer-Verlag New York Inc., New York
-
Brook, I.,
Walker, R. I.
(1985)
Can. J. Microbiol.
31,
176-180
[Medline]
[Order article via Infotrieve]
-
Krepel, C. J.,
Gohr, C. M.,
Walker, A. P.,
Farmer, S. G.,
Edmiston, C. E.
(1992)
J. Clin. Microbiol.
30,
2330-2334
[Abstract/Free Full Text]
-
Kehoe, M. A.
(1994)
New Compr. Biochem.
27,
217-261
-
Reis, K. J.,
Ayoub, E. M.,
Boyle, M. D. P.
(1984)
J. Immunol.
132,
3091-3097
[Abstract]
-
Forsgren, A.,
Sjöquist, J.
(1966)
J. Immunol.
97,
822-827
[Abstract/Free Full Text]
-
Björck, L.,
Kronvall, G.
(1984)
J. Immunol.
133,
969-974
[Abstract]
-
Björck, L.,
Kastern, W.,
Lindahl, G.,
Widebäck, K.
(1987)
Mol. Immunol.
24,
1113-1122
[CrossRef][Medline]
[Order article via Infotrieve]
-
Åkesson, P.,
Schmidt, K.-H.,
Cooney, J.,
Björck, L.
(1994)
Biochem. J.
300,
877-886
-
Retnoningrum, D. S.,
Cleary, P. P.
(1994)
Infect. Immun.
62,
2387-2394
[Abstract/Free Full Text]
-
Schmidt, K.-H.,
Wadström, T.
(1990)
Zentralbl. Bakteriol.
273,
216-228
-
de Château, M.,
Björck, L.
(1994)
J. Biol. Chem.
269,
12147-12151
[Abstract/Free Full Text]
-
Björck, L.
(1988)
J. Immunol.
140,
1194-1197
[Abstract]
-
Kastern, W.,
Holst, E.,
Nielsen, E.,
Sjöbring, U.,
Björck, L.
(1990)
Infect. Immun.
58,
1217-1222
[Abstract/Free Full Text]
-
Patella, V.,
Casolaro, V.,
Björck, L.,
Marone, G.
(1990)
J. Immunol.
145,
3054-3061
[Abstract]
-
Fischetti, V. A.
(1989)
Clin. Microbiol. Rev.
2,
285-314
[Abstract/Free Full Text]
-
Reader, R.,
Boyle, M. D. P.
(1993)
Infect. Immun.
61,
3696-3702
[Abstract/Free Full Text]
-
Foster, T. J.
(1994)
FEMS Microbiol. Lett.
118,
199-206
[CrossRef][Medline]
[Order article via Infotrieve]
-
Schneewind, O.,
Model, P.,
Fischetti, V. A.
(1992)
Cell
70,
267-281
[CrossRef][Medline]
[Order article via Infotrieve]
-
de Château, M.,
Björck, L.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
8490-8495
[Abstract/Free Full Text]
-
Johansson, M. U.,
de Château, M.,
Björck, L.,
Forsén, S.,
Drakenberg, T.,
Wikström, M.
(1995)
FEBS Lett.
374,
257-261
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kraulis, P. J.,
Jonasson, P.,
Nygren, P.-Å.,
Uhlén, M.,
Jendeberg, L.,
Nilsson, B.,
Kördel, J.
(1996)
FEBS Lett.
378,
190-194
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sjöbring, U.
(1992)
Infect. Immun.
60,
3601-3608
[Abstract/Free Full Text]
-
Murphy, J. P.,
Duggleby, C. J.,
Atkinson, M. A.,
Trowern, A. R.,
Atkinson, T.,
Goward, C. R.
(1994)
Mol. Microbiol.
12,
911-920
[CrossRef][Medline]
[Order article via Infotrieve]
-
Jonsson, H.,
Frykberg, L.,
Rantamäki, L.,
Guss, B.
(1994)
Gene (Amst.)
143,
85-89
[CrossRef][Medline]
[Order article via Infotrieve]
-
Jonsson, H.,
Lindmark, H.,
Guss, B.
(1995)
Infect. Immun.
63,
2968-2975
[Abstract]
-
de Château, M.,
Nilson, B. H. K.,
Erntell, M.,
Myhre, E.,
Magnusson, C. G. M.,
Åkerström, B.,
Björck, L.
(1993)
Scand. J. Immunol.
37,
399-405
[CrossRef][Medline]
[Order article via Infotrieve]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685
[CrossRef][Medline]
[Order article via Infotrieve]
-
Towbin, H.,
Staehlin, T.,
Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354
[Abstract/Free Full Text]
-
Johansson, B. G.
(1972)
Scand. J. Clin. Lab. Invest. Suppl.
29,
7-19
-
Åkerström, B.,
Björck, L.
(1989)
J. Biol. Chem.
264,
19740-19746
[Abstract/Free Full Text]
-
Dalböge, H.,
Bech Jensen, E.,
Töttrup, H.,
Grubb, A.,
Abrahamson, M.,
Olafsson, I.,
Carlsen, S.
(1989)
Gene (Amst.)
79,
325-332
[CrossRef][Medline]
[Order article via Infotrieve]
-
Finegold, S. M.
(1995)
Anaerobe
1,
3-9
-
Kastern, W.,
Sjöbring, U.,
Björck, L.
(1992)
J. Biol. Chem.
267,
12820-12825
[Abstract/Free Full Text]
-
Åkerström, B.,
Nielsen, E.,
Björck, L.
(1987)
J. Biol. Chem.
262,
13388-13391
[Abstract/Free Full Text]
-
Moore, L. V. H.,
Cato, E. P.,
Moore, W. E. C.
(1977)
VPI-Anaerobe Laboratory Manual
, 4th Ed.
, Virginia Polytechnic Institute and State University, Blacksburg, VA
-
Ockner, R. K.,
Weisiger, R. A.,
Gollan, J. L.
(1983)
Am. J. Physiol.
245,
G13-G18
[Abstract/Free Full Text]
-
Fahnestock, S. R.,
Alexander, P.,
Nagle, J.,
Filpula, D.
(1986)
J. Bacteriol.
167,
870-880
[Abstract/Free Full Text]
-
Guss, B.,
Eliasson, M.,
Olsson, A.,
Uhlén, M.,
Frej, A.-K.,
Jörnvall, H.,
Flock, J.-I.,
Lindberg, M.
(1986)
EMBO J.
5,
1567-1575
[Medline]
[Order article via Infotrieve]
-
Schägger, H.,
von Jagow, G.
(1987)
Anal. Biochem.
166,
368-379
[CrossRef][Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Karlsson, M. Morgelin, M. Collin, R. Lood, M.-L. Andersson, A. Schmidtchen, L. Bjorck, and I.-M. Frick
SufA - a bacterial enzyme that cleaves fibrinogen and blocks fibrin network formation
Microbiology,
January 1, 2009;
155(1):
238 - 248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. He, Y. Chen, P. Alexander, P. N. Bryan, and J. Orban
NMR structures of two designed proteins with high sequence identity but different fold and function
PNAS,
September 23, 2008;
105(38):
14412 - 14417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Alexander, Y. He, Y. Chen, J. Orban, and P. N. Bryan
The design and characterization of two proteins with 88% sequence identity but different structure and function
PNAS,
July 17, 2007;
104(29):
11963 - 11968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Calderon, E. Carter, K. M. Ramsey, J. A. Vande Waa, W. K. Green, and M. A. Alpert
Necrotizing Fasciitis: A Complication of Percutaneous Coronary Revascularization
Angiology,
June 1, 2007;
58(3):
360 - 366.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lejon, I.-M. Frick, L. Bjorck, M. Wikstrom, and S. Svensson
Crystal Structure and Biological Implications of a Bacterial Albumin Binding Module in Complex with Human Serum Albumin
J. Biol. Chem.,
October 8, 2004;
279(41):
42924 - 42928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. U. Johansson, I.-M. Frick, H. Nilsson, P. J. Kraulis, S. Hober, P. Jonasson, M. Linhult, P.-A. Nygren, M. Uhlen, L. Bjorck, et al.
Structure, Specificity, and Mode of Interaction for Bacterial Albumin-binding Modules
J. Biol. Chem.,
March 1, 2002;
277(10):
8114 - 8120.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|